Long-acting preparations of exenatide

Exenatide has been widely used for the treatment of type 2 diabetes mellitus. However, its short plasma half-life of 2.4 hours has limited its clinical application. The exenatide products on the market, twice-daily Byetta™ and once-weekly Bydureon™ (both Amylin Pharmaceuticals, San Diego, CA, USA),...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yunpeng, Wei, Liangming, Ma, Liuqing, Huang, Xiwen, Tao, Anqi, Liu, Zhenguo, Yuan, Weien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771853/
https://www.ncbi.nlm.nih.gov/pubmed/24039406
http://dx.doi.org/10.2147/DDDT.S46970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771853/
https://www.ncbi.nlm.nih.gov/pubmed/24039406
http://dx.doi.org/10.2147/DDDT.S46970

Ejemplares similares